Methods of modulating neurotrophin-mediated activity

Details Methods of modulating neurotrophin-mediated activity Methods of modulating neurotrophin-mediated activity

2006-09-14

2009-08-25

Padmanabhan, Sreeni (Department: 1617)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C546S102000

Reexamination Certificate

active

07579468

ABSTRACT:
Disclosed are compositions which modulate the interaction with nerve growth factor and precursors thereof with neurotrophic receptors. Also disclosed are methods of using the compositions of the invention, including methods of administration.

REFERENCES:
patent: 3821383 (1974-06-01), Sestanj et al.
patent: 4006238 (1977-02-01), Wade
patent: 4204063 (1980-05-01), Brana et al.
patent: 4254109 (1981-03-01), Sestanj et al.
patent: 4874863 (1989-10-01), Brana et al.
patent: 5076831 (1991-12-01), Saupe et al.
patent: 5183821 (1993-02-01), Brana et al.
patent: 5342942 (1994-08-01), Jaen et al.
patent: 5420137 (1995-05-01), Brana et al.
patent: 5552544 (1996-09-01), Bra na et al.
patent: 5554622 (1996-09-01), Bra na et al.
patent: 5616589 (1997-04-01), Keilhauer et al.
patent: 6015458 (2000-01-01), Schulz et al.
patent: 6029114 (2000-02-01), Shamovsky et al.
patent: 6040331 (2000-03-01), Yamamoto et al.
patent: 6291247 (2001-09-01), Riopelle et al.
patent: 6300331 (2001-10-01), Noguchi et al.
patent: 6403604 (2002-06-01), Yang et al.
patent: 6403797 (2002-06-01), Sandefur et al.
patent: 6468990 (2002-10-01), Ross et al.
patent: 6492380 (2002-12-01), Ross et al.
patent: 6825207 (2004-11-01), Yang et al.
patent: 6855720 (2005-02-01), Yang
patent: 7148352 (2006-12-01), Ross et al.
patent: 7291629 (2007-11-01), Tehim et al.
patent: 2007/0078137 (2007-04-01), Ross et al.
patent: 199943963 (2000-04-01), None
patent: 2323555 (1974-08-01), None
patent: 3707652 (1988-09-01), None
patent: 0206322 (1986-12-01), None
patent: 0268093 (1988-05-01), None
patent: 0430004 (1991-06-01), None
patent: 0728745 (1996-08-01), None
patent: 2521139 (1983-08-01), None
patent: 2002-154984 (2002-05-01), None
patent: WO-98/06048 (1998-02-01), None
patent: WO-98/17278 (1998-04-01), None
patent: WO-00/00472 (2000-01-01), None
patent: WO-00/69828 (2000-11-01), None
patent: WO-00/69829 (2000-11-01), None
patent: WO-03/101998 (2003-12-01), None
patent: WO-2005/076695 (2005-08-01), None
patent: WO-2006/027628 (2006-03-01), None
patent: WO-2007/030940 (2007-03-01), None
Ares, Jeffrey J. et al., “Synthesis and Biological Evaluation of Irreversible Inhibitors of Aldose Reductase,”J. Med. Chem., vol. 29:2384-2389 (1986).
Biczók, László et al., “Effect of molecular structure and hydrogen bonding on the fluorescence of hydroxy-substituted naphthalimides,”Phys. Chem. Chem. Phys., vol. 1:4759-4766 (1999).
Braña, Mibuel F. et al., “Enediynes as Antitumor Compounds: Synthesis of Tetrahydropyridine Derivatives,”J. Org. Chem., vol. 61:1369-1374 (1996).
Braña, Mibuel Fernández et al., “Synthesis and cytostatic activity of benz(de)iso-quinolin-1,3-diones. Structure-activity relationships,”Eur. J. Med. Chem., vol. 16(3):207-212 (1981).
Chapman, James M. Jr. et al., “Hypolipidemic Activity of Phthalimide Derivatives IV: Further Chemical Modification and Investigation of the Hypolipidemic Activity ofN-Substituted Imides,”Journal of Pharmaceutical Sciences, vol. 72(11):1344-1347 (1983).
Chapman, James M. Jr. et al., “Hypolipidemic Activity of Phthalimide Derivatives V: Reduced and Hydrolytic Products of Simple Cyclic Imides,”Journal of Pharmaceutical Sciences, vol. 73(10):1482-1484 (1984).
Costi, M.P. et al., “Naphthalimido derivatives as antifolate thymidylate synthase inhibitors,”Eur. J. Med. Chem., vol. 31:1011-1016 (1996).
Donkor, Isaac O. et al., “Synthesis and biological activities of aldose reductase inhibitors bearing acyl benzenesulfonamides as carboxylic acid surrogates,”Eur. J. Med. Chem., vol. 33:15-22 (1998).
Donkor, Isaac O. et al., “Synthesis and biological activity of aldose reductase inhibitors with Michael acceptor substituents,”Eur. J. Med. Chem., vol. 34:235-243 (1999).
Dubey, Krishna K. et al., “A novel bifunctional fluorescent tag for use in molecular biology,”Indian Journal of Chemistry, vol. 34B:876-878 (1995).
El-Naggar, A.M. et al., “Synthesis and biological activity of some new 3,6-dinitro-1:8-naphthaloyl- and 3,6-diamino-1:8-naphthaloylamino acids and dipeptide derivatives,”International Journal of Peptide&Protein Research, vol. 20(1):1-7 (1982).
El-Naggar, A.M. et al., “Synthesis of some 3-hydroxynaphthalene-2-carbonylamino acid and dipeptide derivatives,”Int. J. Peptide Protein Res., vol. 22:251-256 (1983).
Hodgkiss, R.J. et al., “Fluorescent Markers for Hypoxic Cells, A Study of Novel Heterocyclic Compounds that Undergo Bio-Reductive Binding,”Biochemical Pharmacology, vol. 41(4):533-541 (1991).
Hodgkiss, R.J. et al., “Toxicity of 3-Nitronaphthalimides to V79 379A Chinese Hamster Cells,”Biochemical Pharmacology, vol. 36(9):1483-1487 (1987).
Jaen, Juan C. et al., “Kynurenic Acid Derivatives Inhibit the Binding of Nerve Growth Factor (NGF) to the Low-Affinity p75 NGF Receptor,”J. Med. Chem., vol. 38:4439-4445 (1995).
Kador, Peter F. et al., “Irreversible Aldose Reductase Inhibitors,”Enzymology and Molecular Biology of Carbonyl Metabolism, pp. 353-365 (1987).
LeSauteur, Lynne et al., “Small Peptide Mimics of Nerve Growth Factor Bind TrkA Receptors and Affect Biological Responses,”The Journal of Biological Chemistry, vol. 270(12):6564-6569 (1995).
Nishizaki, S., “Infrared spectra of N-substituted naphthalimides,”Nippon Kagaku Zasshi, vol. 86(7):696-699 (1965).
Owolabi, Joshua B. et al., “Characterization of Antiallodynic Actions of ALE-0540, a Novel Nerve Growth Factor Receptor Antagbonist, in the Rat,”The Journal of Pharmacology and Experimental Therapeutics, vol. 289(3):1271-1276 (1999).
Spiegel, Katharyn et al., “PD 90780, A Nonpeptide Inhibitor of Nerve Growth Factor's Binding to the P75 NGF Receptor,”Blochemical and Biophysical Research Communciations, vol. 217(2):488-494 (1995).
Szadowski, Jerzy et al., “Properties of monoazo pigments containing heterocyclic amide groups,” CAplus Accession No. 108:154305 (1978).
Szadowski, Jerzy et al., Przemysl Chemizny, vol. 57(2):70-74 (1978).
Tyman, John Henry Paul, “Fluorescent naphthalimide dyes,” CAplus Accession No. 108:7506 (1997).
International Search Report for Application No. PCT/CA2006/001517, dated Jan. 30, 2007.

Affiliated with

Also associated with

Rating

Methods of modulating neurotrophin-mediated activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of modulating neurotrophin-mediated activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of modulating neurotrophin-mediated activity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4084861